Literature DB >> 33722340

The global burden of yellow fever.

Katy Am Gaythorpe1, Arran Hamlet1, Kévin Jean2, Daniel Garkauskas Ramos3, Laurence Cibrelus4, Tini Garske1, Neil Ferguson1.   

Abstract

Yellow fever (YF) is a viral, vector-borne, haemorrhagic fever endemic in tropical regions of Africa and South America. The vaccine for YF is considered safe and effective, but intervention strategies need to be optimised; one of the tools for this is mathematical modelling. We refine and expand an existing modelling framework for Africa to account for transmission in South America. We fit to YF occurrence and serology data. We then estimate the subnational forces of infection for the entire endemic region. Finally, using demographic and vaccination data, we examine the impact of vaccination activities. We estimate that there were 109,000 (95% credible interval [CrI] [67,000-173,000]) severe infections and 51,000 (95% CrI [31,000-82,000]) deaths due to YF in Africa and South America in 2018. We find that mass vaccination activities in Africa reduced deaths by 47% (95% CrI [10%-77%]). This methodology allows us to evaluate the effectiveness of vaccination and illustrates the need for continued vigilance and surveillance of YF.
© 2021, Gaythorpe et al.

Entities:  

Keywords:  epidemiology; global health; mathematical modelling; vaccine impact; vector-borne; virus; yellow fever

Mesh:

Substances:

Year:  2021        PMID: 33722340      PMCID: PMC7963473          DOI: 10.7554/eLife.64670

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  35 in total

Review 1.  Yellow fever.

Authors:  Thomas P Monath; Pedro F C Vasconcelos
Journal:  J Clin Virol       Date:  2014-10-24       Impact factor: 3.168

2.  Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017–2026.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2017-04-21

3.  Evidence for multiple sylvatic transmission cycles during the 2016-2017 yellow fever virus outbreak, Brazil.

Authors:  A Moreira-Soto; M C Torres; M C Lima de Mendonça; M A Mares-Guia; C D Dos Santos Rodrigues; A A Fabri; C C Dos Santos; E S Machado Araújo; C Fischer; R M Ribeiro Nogueira; C Drosten; P Carvalho Sequeira; J F Drexler; A M Bispo de Filippis
Journal:  Clin Microbiol Infect       Date:  2018-02-07       Impact factor: 8.067

4.  [Prevalence of yellow fever antibodies in north Zaire].

Authors:  G T Werner; H C Huber; K Fresenius
Journal:  Ann Soc Belg Med Trop       Date:  1985

5.  [Evaluation of immunological and entomotological indices of yellow fever in Pointe-Noire, People's Republic of Congo].

Authors:  M Merlin; R Josse; D Kouka-Bemba; D Meunier; J Senga; E Simonkovich; J R Malonga; F Manoukou; A J Georges
Journal:  Bull Soc Pathol Exot Filiales       Date:  1986

6.  Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.

Authors:  J Erin Staples; Joseph A Bocchini; Lorry Rubin; Marc Fischer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-19       Impact factor: 17.586

7.  The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus.

Authors:  Moritz U G Kraemer; Marianne E Sinka; Kirsten A Duda; Adrian Q N Mylne; Freya M Shearer; Christopher M Barker; Chester G Moore; Roberta G Carvalho; Giovanini E Coelho; Wim Van Bortel; Guy Hendrickx; Francis Schaffner; Iqbal R F Elyazar; Hwa-Jen Teng; Oliver J Brady; Jane P Messina; David M Pigott; Thomas W Scott; David L Smith; G R William Wint; Nick Golding; Simon I Hay
Journal:  Elife       Date:  2015-06-30       Impact factor: 8.140

8.  Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations.

Authors:  Dinair Couto-Lima; Yoann Madec; Maria Ignez Bersot; Stephanie Silva Campos; Monique de Albuquerque Motta; Flávia Barreto Dos Santos; Marie Vazeille; Pedro Fernando da Costa Vasconcelos; Ricardo Lourenço-de-Oliveira; Anna-Bella Failloux
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

9.  Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.

Authors:  Mark D Gershman; Kristina M Angelo; Julian Ritchey; David P Greenberg; Riyadh D Muhammad; Gary Brunette; Martin S Cetron; Mark J Sotir
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-05-05       Impact factor: 17.586

10.  Heterogeneous feeding patterns of the dengue vector, Aedes aegypti, on individual human hosts in rural Thailand.

Authors:  Laura C Harrington; Andrew Fleisher; Diego Ruiz-Moreno; Francoise Vermeylen; Chrystal V Wa; Rebecca L Poulson; John D Edman; John M Clark; James W Jones; Sangvorn Kitthawee; Thomas W Scott
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
View more
  22 in total

1.  Monoclonal Antibodies and Flaviviruses: a Possible Option?

Authors:  Nicasio Mancini
Journal:  mBio       Date:  2022-05-16       Impact factor: 7.786

2.  Yellow fever vaccination before and during the covid-19 pandemic in Brazil.

Authors:  Tércia Moreira Ribeiro da Silva; Ana Carolina Micheletti Gomide Nogueira de Sá; Elton Junio Sady Prates; Daiana Elias Rodrigues; Thales Philipe Rodrigues da Silva; Fernanda Penido Matozinhos; Ed Wilson Rodrigues Vieira
Journal:  Rev Saude Publica       Date:  2022-06-13       Impact factor: 2.772

Review 3.  Yellow fever outbreak in Kenya: A review.

Authors:  Olivier Uwishema; Stanley Chinedu Eneh; Anyike Goodness Chiburoma; Wael Atif Fadl Elhassan; Adeniji Abdur-Rahman Adekunle; Martin Sagide Rogose; ElShimaa Zaki; Aymar Akilimali; Helen Onyeaka
Journal:  Ann Med Surg (Lond)       Date:  2022-09-01

4.  Yellow fever in Asia-a risk analysis.

Authors:  Bethan Cracknell Daniels; Katy Gaythorpe; Natsuko Imai; Ilaria Dorigatti
Journal:  J Travel Med       Date:  2021-04-14       Impact factor: 8.490

5.  Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.

Authors:  Michael P Doyle; Joseph R Genualdi; Adam L Bailey; Nurgun Kose; Christopher Gainza; Jessica Rodriguez; Kristen M Reeder; Christopher A Nelson; Prashant N Jethva; Rachel E Sutton; Robin G Bombardi; Michael L Gross; Justin G Julander; Daved H Fremont; Michael S Diamond; James E Crowe
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

6.  Inoculation route-dependent Lassa virus dissemination and shedding dynamics in the natural reservoir - Mastomys natalensis.

Authors:  D M Wozniak; S A Riesle-Sbarbaro; N Kirchoff; K Hansen-Kant; A Wahlbrink; A Stern; A Lander; K Hartmann; S Krasemann; A Kurth; J Prescott
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

7.  Exploring relationships between drought and epidemic cholera in Africa using generalised linear models.

Authors:  Gina E C Charnley; Ilan Kelman; Nathan Green; Wes Hinsley; Katy A M Gaythorpe; Kris A Murray
Journal:  BMC Infect Dis       Date:  2021-11-22       Impact factor: 3.090

8.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.

Authors:  Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

9.  Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.

Authors:  Katy Am Gaythorpe; Kaja Abbas; John Huber; Andromachi Karachaliou; Niket Thakkar; Matthew Ferrari; Michael L Jackson; Kevin McCarthy; T Alex Perkins; Caroline Trotter; Mark Jit; Kim Woodruff; Xiang Li; Susy Echeverria-Londono
Journal:  Elife       Date:  2021-06-24       Impact factor: 8.140

10.  Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever Virus.

Authors:  Victor O Gawriljuk; Daniel H Foil; Ana C Puhl; Kimberley M Zorn; Thomas R Lane; Olga Riabova; Vadim Makarov; Andre S Godoy; Glaucius Oliva; Sean Ekins
Journal:  J Chem Inf Model       Date:  2021-07-21       Impact factor: 6.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.